Browse Pet Safety Reports
16,709 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 16,709 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product, widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 16,709 FDA veterinary adverse event reports for Human.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Oct 16, 2019 | Human | Unknown | Tulathromycin | Puncture wound; Injection site pain | Outcome Unknown |
| Oct 16, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Medication error | Recovered/Normal |
| Oct 15, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Rash; Skin sore | Ongoing |
| Oct 14, 2019 | Human | Unknown | Oclacitinib Maleate | Feeling anxious; Light headedness | Outcome Unknown |
| Oct 14, 2019 | Human | Unknown | Florfenicol/Flunixin Inj-Triac | Puncture wound; Injection site irritation | Ongoing |
| Oct 12, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Itching; Rash; Warm feeling to the touch; Peeling skin | Ongoing |
| Oct 12, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Itching; Rash; Warm feeling to the touch; Peeling skin; Skin irritation | Ongoing |
| Oct 10, 2019 | Human | Unknown | Tilmicosin | Chest tightness; Chest discomfort NOS | Outcome Unknown |
| Oct 10, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Difficulty of Use | Ongoing |
| Oct 10, 2019 | Human | Unknown | Florfenicol; Terbinafine Hydrochlorid... | Eye irritation | Outcome Unknown |
| Oct 9, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS | Ongoing |
| Oct 9, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Containers, Leaking; Difficulty of Use | Recovered/Normal |
| Oct 9, 2019 | Human | Unknown | Florfenicol; Terbinafine Hydrochlorid... | Ocular burn; Eye pain; Burning sensation of eye | Outcome Unknown |
| Oct 8, 2019 | Human | Unknown | Cefovecin | Eye stinging | Outcome Unknown |
| Oct 8, 2019 | Human | Unknown | Ceftiofur Crystalline Free Acid | Puncture wound; Pain NOS | Ongoing |
| Oct 8, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Medication error | Recovered/Normal |
| Oct 8, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Bad taste | Ongoing |
| Oct 7, 2019 | Human | Unknown | Afoxolaner | Anaphylactoid reaction | Outcome Unknown |
| Oct 5, 2019 | Human | Unknown | Lotilaner | Headache | Ongoing |
| Oct 4, 2019 | Human | Unknown | Phytosphingosine Salicyloyl; Ketocona... | Application site skin discolouration; Product problem; Color, Abnormal | Outcome Unknown |
| Oct 3, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Medication error; Application site skin change NOS | Ongoing |
| Oct 2, 2019 | Human | Unknown | Selamectin;Sarolaner | Headache; Nausea; Lethargy (see also Central nervous system depression in 'Ne... | Outcome Unknown |
| Oct 2, 2019 | Human | Unknown | Nitenpyram | Welt; Itching | Ongoing |
| Oct 1, 2019 | Human | Unknown | Milbemycin Oxime; Lufenuron; Praziqua... | Epiphora | Recovered/Normal |
| Sep 30, 2019 | Human | Unknown | Tulathromycin | Puncture wound | Outcome Unknown |
| Sep 30, 2019 | Human | Unknown | Selamectin | Chest tightness | Outcome Unknown |
| Sep 30, 2019 | Human | Unknown | Afoxolaner | Inappetence; Fever | Outcome Unknown |
| Sep 28, 2019 | Human | Unknown | Moxidectin | Injection site bruising; Injection site irritation | Outcome Unknown |
| Sep 27, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Appearance, Abnormal; Tubes, Leaking | Ongoing |
| Sep 26, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS | Ongoing |
| Sep 26, 2019 | Human | Unknown | Imidacloprid; Moxidectin | Taste alteration; Tongue paraesthesia; Accidental exposure | Recovered/Normal |
| Sep 26, 2019 | Human | Unknown | Gamithromycin | Injection site bleeding; Injection site pain | Outcome Unknown |
| Sep 25, 2019 | Human | Unknown | Tilmicosin | Headache; Tingling sensation; Throat tightness; Bad taste; Accidental exposure | Recovered/Normal |
| Sep 25, 2019 | Human | Unknown | Amprolium | No sign | Outcome Unknown |
| Sep 24, 2019 | Human | Unknown | Selamectin;Sarolaner | Burn | Outcome Unknown |
| Sep 23, 2019 | Human | Unknown | Florfenicol; Terbinafine Hydrochlorid... | Eye irritation | Recovered/Normal |
| Sep 23, 2019 | Human | Unknown | Tulathromycin | Puncture wound; Injection site pain | Ongoing |
| Sep 22, 2019 | Human | Unknown | Neomycin Sulfate; Thiabendazole; Dexa... | Sore eye; Eye irritation | Recovered/Normal |
| Sep 22, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS | Recovered/Normal |
| Sep 20, 2019 | Human | Unknown | Tulathromycin | Puncture wound; Injection site pain | Ongoing |
| Sep 20, 2019 | Human | Unknown | Moxidectin | Puncture wound; Laceration; Injection site bleeding; Accidental exposure | Recovered/Normal |
| Sep 20, 2019 | Human | Unknown | Tulathromycin | Puncture wound | Outcome Unknown |
| Sep 20, 2019 | Human | Unknown | Rabacfosadine | Stinging skin | Outcome Unknown |
| Sep 18, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Eye irritation; Eye redness | Ongoing |
| Sep 18, 2019 | Human | Unknown | Florfenicol; Terbinafine Hydrochlorid... | Eye irritation | Recovered/Normal |
| Sep 17, 2019 | Human | Unknown | Eprinomectin; Praziquantel | Product problem; Dispenser, Abnormal | Outcome Unknown |
| Sep 17, 2019 | Human | Unknown | Rabacfosadine | Injection site bleeding | Recovered/Normal |
| Sep 17, 2019 | Human | Unknown | Pimobendan | Headache; Increased heart rate; High blood pressure | Recovered/Normal |
| Sep 17, 2019 | Human | Unknown | Mirtazapine | Eyelid inflammation; Localised rash | Recovered/Normal |
| Sep 17, 2019 | Human | Unknown | Tiletamine Hcl;Zolazapam Hcl | Unexplained death | Died |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe, difficulty breathing, seizures, collapse, or severe swelling, seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.